Mead Johnson Nutrition reported an increase in earnings today (22 October) for the first nine months of the year, in what it described as a “solid performance”.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
For the period ended 30 September non-GAAP net earnings increased to US$356.9m, up 13% from a year ago.
Non-GAAP net sales of $2.11bn were down 2% compared with 2008. Excluding foreign exchange, sales increased 4%.
EBIT increased to $593.5m in the first nine months of 2009, up from $573.1m in the prior year.
“Our solid performance reflects the success of our global growth strategies,” said Mead Johnson CEO Stephen Golsby. “Our sales performance in constant dollars reflects continued double-digit growth in Asia and Latin America, as we continue to launch new products, strengthen our marketing programmes and expand our distribution footprint in China.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company said it expects to report non-GAAP EPS in the range of $2.20 to $2.25 for 2009, which is at the high end of its previous range of $2.15 to $2.25, up 17% from $1.90 per share in 2008.
Last month, Mead Johnson Nutrition earmarked a site in Evansville, Indiana for the building of a US$32.8m powder blending and packaging facility.
The company said that the plant will “enhance” its ability to respond to the growing consumer preference for powdered infant formula products.
